In this study we tested whether intravenously injected C17.2 NSCs could improve the neurological functional recovery and reduction of cerebral infarction volume caused by focal cerebral ischemia in rats. Furthermore, we determined the migration, proliferation and differentiation capabilites of transplanted C17.2 NSCs in the ischemic brain microenvironment.